Skip to Main content Skip to Navigation
Journal articles

Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group

Abstract : 57th Annual Meeting of the American-Society-of-Hematology Location: Orlando, FL Date: DEC 05-08, 2015
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01300812
Contributor : Laurent Jonchère <>
Submitted on : Monday, April 11, 2016 - 2:15:11 PM
Last modification on : Wednesday, August 19, 2020 - 11:18:09 AM

Identifiers

  • HAL Id : hal-01300812, version 1

Citation

Lionel Adès, Xavier Thomas, Agnes Cuerci-Bres, Raffoux Emmanuel, Olivier Spertini, et al.. Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group. Blood, American Society of Hematology, 2015, 126 (23), pp.451. ⟨hal-01300812⟩

Share

Metrics

Record views

470